Case study 01 · EU MDR
Clinical Evaluation Strategy & CER Development for EU MDR Compliance
A medical device manufacturer required support developing a Clinical Evaluation Report (CER) for a Class IIb device. The challenge extended beyond document preparation — the client needed a structured clinical evidence strategy capable of supporting regulatory compliance, minimising rework and ensuring consistency across the product lifecycle. A four-stage framework was implemented: Discovery, Strategy, Execution and Defense.
The challenges
- Limited clarity on the strength and sufficiency of existing clinical evidence (routes of clinical evidence required)
- Potential gaps between intended purpose, risk management and clinical claims
- The need for an audit-ready Clinical Evaluation Report
- A requirement for alignment between CER, Risk and Technical Documentation
- Future preparedness for Notified Body review and post-market evidence updates
Discovery & Regulatory Deep Dive
A detailed assessment of the device and its targeted regulatory market.
- Review of the device in detail — technology, intended purpose, target population
- Assessment of regulatory classification and pathway
- Evaluation of existing technical and available clinical documentation
Clinical Evidence Strategy
Identifying evidence requirements and building a defensible clinical argument through the data sets.
- Indications and claims mapping with State-of-the-Art assessment
- Critical literature appraisal and benchmark evaluation
- Safety and performance parameters from all clinical datasets
- Benefit-risk assessment planning and identification of evidence gaps
Reproducible Regulatory Execution
Translating the strategy into regulatory deliverables aligned with EU MDR expectations.
- Clinical Evaluation Report (CER)
- Clinical evidence appraisal and data-set synthesis
- Benefit-risk evaluation
- Cross-functional alignment
Defending the Clinical Evidence
Maintaining defensibility throughout regulatory review from the Notified Body.
- Preparation for potential Notified Body questions and responses
- Evidence traceability review
- Alignment of clinical conclusions with risk management outputs
- Support for post-market evidence generation (where required)
Key takeaway
A successful Clinical Evaluation Report is the core evidence narrative proving safety, performance, risk management, post-market surveillance and regulatory strategy. By focusing on clarity, accuracy and proactive execution from the outset, the project delivered a predictable pathway toward compliance — with fewer surprises, fewer revisions and on-time delivery.